Bright Minds Biosciences ... (DRUG)
NASDAQ: DRUG
· Real-Time Price · USD
28.27
0.46 (1.65%)
At close: Jun 06, 2025, 3:59 PM
27.53
-2.62%
After-hours: Jun 06, 2025, 05:47 PM EDT
1.65% (1D)
| Bid | 27.1 |
| Market Cap | 200.24M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.06M |
| EPS (ttm) | -0.14 |
| PE Ratio (ttm) | -201.93 |
| Forward PE | -7.1 |
| Analyst | Buy |
| Ask | 28.99 |
| Volume | 18,914 |
| Avg. Volume (20D) | 30,819 |
| Open | 27.66 |
| Previous Close | 27.81 |
| Day's Range | 27.50 - 29.00 |
| 52-Week Range | 0.93 - 79.02 |
| Beta | 0.45 |
About DRUG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DRUG
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DRUG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-1.24%
Bright Minds Biosciences shares are trading higher...
Unlock content with
Pro Subscription
7 months ago
+1.72%
Bright Minds Biosciences shares are trading higher after the company announced a collaboration with Firefly Neuroscience to provide a full analysis of the EEG data in the BREAKTHROUGH study.
